Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01099410 · ClinicalTrials.gov registry record
Apoptotic Cell (AC) Uptake by Human Alveolar Macrophages (AM)
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 17
- Enrollment target
NCT01099410: Completed study, sponsored by VA Office of Research and Development.
NCT01099410 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01099410 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the ability of two types of white blood cells to eat dead host cells, and how this process affects their ability to protect the body from infection. The two cell types are monocytes, a cell in the bloodstream, and alveolar macrophages, a cell in the lung that is ultimately derived from monocytes
Interventions
- PROCEDURE blood draw
- PROCEDURE Fiberoptic bronchoscopy
- PROCEDURE intravenous catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2010-02 |
| Est. Completion | 2015-12 |
What the finished NCT01099410 record still lists
NCT01099410 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which blood draw is the first listed.
NCT01099410 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01099410 about?
NCT01099410 is a clinical study titled "Apoptotic Cell (AC) Uptake by Human Alveolar Macrophages (AM)". The purpose of this study is to compare the ability of two types of white blood cells to eat dead host cells, and how this process affects their ability to protect the body from infection. The two cell types are monocytes, a cell in the bloodstream, and alveolar macrophages, a cell in the lung that ...
What is the current status of trial NCT01099410?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2010-02. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01099410?
The interventions under investigation include: blood draw (PROCEDURE), Fiberoptic bronchoscopy (PROCEDURE), intravenous catheter (PROCEDURE).
Who is sponsoring clinical trial NCT01099410?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia